291 related articles for article (PubMed ID: 23040422)
21. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial.
Simmons RK; Sharp SJ; Sandbæk A; Borch-Johnsen K; Davies MJ; Khunti K; Lauritzen T; Rutten GE; van den Donk M; Wareham NJ; Griffin SJ
Diabet Med; 2012 Nov; 29(11):e409-16. PubMed ID: 22823477
[TBL] [Abstract][Full Text] [Related]
22. Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial.
Griffin SJ; Simmons RK; Prevost AT; Williams KM; Hardeman W; Sutton S; Brage S; Ekelund U; Parker RA; Wareham NJ; Kinmonth AL;
Diabetologia; 2014 Jul; 57(7):1308-19. PubMed ID: 24759957
[TBL] [Abstract][Full Text] [Related]
23. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
Sortsø C; Komkova A; Sandbæk A; Griffin SJ; Emneus M; Lauritzen T; Simmons RK
Diabetologia; 2018 Jun; 61(6):1306-1314. PubMed ID: 29549417
[TBL] [Abstract][Full Text] [Related]
24. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
[TBL] [Abstract][Full Text] [Related]
25. Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.
Simmons RK; Rahman M; Jakes RW; Yuyun MF; Niggebrugge AR; Hennings SH; Williams DR; Wareham NJ; Griffin SJ
Diabetologia; 2011 Feb; 54(2):312-9. PubMed ID: 20978739
[TBL] [Abstract][Full Text] [Related]
26. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening.
Lauritzen T; Griffin S; Borch-Johnsen K; Wareham NJ; Wolffenbuttel BH; Rutten G;
Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S6-11. PubMed ID: 11063279
[TBL] [Abstract][Full Text] [Related]
27. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
28. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.
Sandbaek A; Griffin SJ; Rutten G; Davies M; Stolk R; Khunti K; Borch-Johnsen K; Wareham NJ; Lauritzen T
Diabetologia; 2008 Jul; 51(7):1127-34. PubMed ID: 18443762
[TBL] [Abstract][Full Text] [Related]
29. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.
Webb DR; Gray LJ; Khunti K; Srinivasan B; Taub N; Campbell S; Barnett J; Farooqi A; Echouffo-Tcheugui JB; Griffin SJ; Wareham NJ; Davies MJ
Diabetologia; 2011 Sep; 54(9):2237-46. PubMed ID: 21638133
[TBL] [Abstract][Full Text] [Related]
30. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
[TBL] [Abstract][Full Text] [Related]
31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
32. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
[TBL] [Abstract][Full Text] [Related]
33. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
[TBL] [Abstract][Full Text] [Related]
34. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.
Strelitz J; Ahern AL; Long GH; Boothby CE; Wareham NJ; Griffin SJ
Cardiovasc Diabetol; 2019 Aug; 18(1):98. PubMed ID: 31370851
[TBL] [Abstract][Full Text] [Related]
35. Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.
Simmons RK; Carlsen AH; Griffin SJ; Charles M; Christiansen JS; Borch-Johnsen K; Sandbaek A; Lauritzen T
Diabet Med; 2014 Dec; 31(12):1577-85. PubMed ID: 25185778
[TBL] [Abstract][Full Text] [Related]
36. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.
Park P; Simmons RK; Prevost AT; Griffin SJ
BMC Public Health; 2008 Oct; 8():350. PubMed ID: 18840266
[TBL] [Abstract][Full Text] [Related]
37. Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.
Echouffo-Tcheugui JB; Simmons RK; Prevost AT; Williams KM; Kinmonth AL; Wareham NJ; Griffin SJ
Ann Fam Med; 2015 Mar; 13(2):149-57. PubMed ID: 25755036
[TBL] [Abstract][Full Text] [Related]
38. Screening for type 2 diabetes mellitus.
Peer N; Balakrishna Y; Durao S
Cochrane Database Syst Rev; 2020 May; 5(5):CD005266. PubMed ID: 32470201
[TBL] [Abstract][Full Text] [Related]
39. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
Diabet Med; 2012 Jul; 29(7):893-904. PubMed ID: 22340130
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
